These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21734565)

  • 21. The innate immune roles of host factors TRIM5α and Cyclophilin A on HIV-1 replication.
    Kuang YQ; Liu HL; Zheng YT
    Med Microbiol Immunol; 2015 Oct; 204(5):557-65. PubMed ID: 25894765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting HIV-1 innate immune responses therapeutically.
    Ellegård R; Shankar EM; Larsson M
    Curr Opin HIV AIDS; 2011 Sep; 6(5):435-43. PubMed ID: 21734566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate immunity and HIV-1 infection.
    Lehner T; Wang Y; Whittall T; Seidl T
    Adv Dent Res; 2011 Apr; 23(1):19-22. PubMed ID: 21441475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human immunodeficiency virus, restriction factors, and interferon.
    Neil S; Bieniasz P
    J Interferon Cytokine Res; 2009 Sep; 29(9):569-80. PubMed ID: 19694548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of the innate immune response in the airway.
    Brasier AR; Zhao Y
    Adv Exp Med Biol; 2014; 795():233-54. PubMed ID: 24162913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of neutrophil hyporesponse and the role of Toll-like receptors in human immunodeficiency virus 1 protection.
    Hernandez JC; Giraldo DM; Paul S; Urcuqui-Inchima S
    PLoS One; 2015; 10(3):e0119844. PubMed ID: 25785697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The emerging role of innate immunity in protection against HIV-1 infection.
    Lehner T; Wang Y; Pido-Lopez J; Whittall T; Bergmeier LA; Babaahmady K
    Vaccine; 2008 Jun; 26(24):2997-3001. PubMed ID: 18180080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innate antiviral response: role in HIV-1 infection.
    Pitha PM
    Viruses; 2011 Jul; 3(7):1179-203. PubMed ID: 21994776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection.
    Jiang G; Santos Rocha C; Hirao LA; Mendes EA; Tang Y; Thompson GR; Wong JK; Dandekar S
    mBio; 2017 May; 8(3):. PubMed ID: 28465428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphisms of innate immunity genes influence disease progression in HIV-1-infected children.
    Freguja R; Gianesin K; Del Bianco P; Malacrida S; Rampon O; Zanchetta M; Giaquinto C; De Rossi A
    AIDS; 2012 Mar; 26(6):765-8. PubMed ID: 22269973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Innate Genes in HIV Replication.
    Schott K; Riess M; König R
    Curr Top Microbiol Immunol; 2018; 419():69-111. PubMed ID: 28685292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers.
    Kikuchi T; Iwabu Y; Tada T; Kawana-Tachikawa A; Koga M; Hosoya N; Nomura S; Brumme ZL; Jessen H; Pereyra F; Trocha A; Walker BD; Iwamoto A; Tokunaga K; Miura T
    J Virol; 2015 May; 89(9):4992-5001. PubMed ID: 25717111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tactics used by HIV-1 to evade host innate, adaptive, and intrinsic immunities.
    Lu L; Yu F; DU LY; Xu W; Jiang SB
    Chin Med J (Engl); 2013 Jun; 126(12):2374-9. PubMed ID: 23786957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of single-nucleotide polymorphisms in TLR7 (Gln11Leu) and TLR9 (1635A/G) with a higher CD4T cell count during HIV infection.
    Said EA; Al-Yafei F; Zadjali F; Hasson SS; Al-Balushi MS; Al-Mahruqi S; Koh CY; Al-Naamani K; Al-Busaidi JZ; Idris MA; Balkhair A; Al-Jabri AA
    Immunol Lett; 2014 Jul; 160(1):58-64. PubMed ID: 24747071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. APOBEC3 Proteins in Viral Immunity.
    Stavrou S; Ross SR
    J Immunol; 2015 Nov; 195(10):4565-70. PubMed ID: 26546688
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular restriction factors affecting the early stages of HIV replication.
    Perez O; Hope TJ
    Curr HIV/AIDS Rep; 2006 Feb; 3(1):20-5. PubMed ID: 16522255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interplay between HIV-1 and Toll-like receptors in human myeloid cells: friend or foe in HIV-1 pathogenesis?
    Donninelli G; Gessani S; Del Cornò M
    J Leukoc Biol; 2016 Jan; 99(1):97-105. PubMed ID: 26307548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies.
    Mohammadzadeh N; Follack TB; Love RP; Stewart K; Sanche S; Chelico L
    Virology; 2019 Jan; 527():21-31. PubMed ID: 30448640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune quiescence: a model of protection against HIV infection.
    Card CM; Ball TB; Fowke KR
    Retrovirology; 2013 Nov; 10():141. PubMed ID: 24257114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-1, interferon and the interferon regulatory factor system: an interplay between induction, antiviral responses and viral evasion.
    Marsili G; Remoli AL; Sgarbanti M; Perrotti E; Fragale A; Battistini A
    Cytokine Growth Factor Rev; 2012; 23(4-5):255-70. PubMed ID: 22748237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.